Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Thomas W Flaig & L Michael Glodé. (2008) Management of the side effects of androgen deprivation therapy in men with prostate cancer. Expert Opinion on Pharmacotherapy 9:16, pages 2829-2841.
Read now
Read now
Articles from other publishers (14)
Keith A. Hall & Edward J. Filardo. (2023) The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer. Cells 12:20, pages 2460.
Crossref
Crossref
Weiwei Yao, Peirong Wang, Huihui Yang, Xiaohui Pu & Jinfei Yang. (2022) Development of Potent ERα Inhibitors: Effectively Inhibit the Growth of Breast Cancer Cells. ChemistrySelect 7:28.
Crossref
Crossref
Yunfei Liao, Slim Sassi, Stefan Halvorsen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek & Zhenfeng Duan. (2017) Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11. Scientific Reports 7:1.
Crossref
Crossref
Bradley D. Anawalt. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
2421
2430.e5
.
Stefan Latz, Christian Fisang, Wolfram Ebert, Stefan Orth, Dirk G. Engehausen, Stefan C. M?ller & Ralf Anding. (2015) Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only. Case Reports in Urology 2015, pages 1-3.
Crossref
Crossref
Lev M. Berstein. 2015. Resistance to Aromatase Inhibitors in Breast Cancer. Resistance to Aromatase Inhibitors in Breast Cancer
261
285
.
Landon W. Trost, Ege Serefoglu, Ahmet Gokce, Brian J. Linder, Alton O. Sartor & Wayne J.G. Hellstrom. (2013) Androgen Deprivation Therapy Impact on Quality of Life and Cardiovascular Health, Monitoring Therapeutic Replacement. The Journal of Sexual Medicine 10:Supplement_1, pages 84-101.
Crossref
Crossref
Rowan G Casey, Niall M Corcoran & S Larry Goldenberg. (2012) Quality of life issues in men undergoing androgen deprivation therapy: a review. Asian Journal of Andrology 14:2, pages 226-231.
Crossref
Crossref
Joanna Beate Korda & Frank Sommer. (2010) Die antiandrogene Therapie aus urologischer SichtAnti-androgen treatment of paraphilias from the urologist’s perspective. Forensische Psychiatrie, Psychologie, Kriminologie 4:S1, pages 17-21.
Crossref
Crossref
Stacy Elliott, David M. Latini, Lauren M. Walker, Richard Wassersug, John W. Robinson & ADT Survivorship Working Group. (2010) Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life. The Journal of Sexual Medicine 7:9, pages 2996-3010.
Crossref
Crossref
Ramesh Narayanan, Muralimohan Yepuru, Adam T. Szafran, Maria Szwarc, Casey E. Bohl, Natalie L. Young, Duane D. Miller, Michael A. Mancini & James T. Dalton. (2010) Discovery and Mechanistic Characterization of a Novel Selective Nuclear Androgen Receptor Exporter for the Treatment of Prostate Cancer. Cancer Research 70:2, pages 842-851.
Crossref
Crossref
Seth A. Rosenthal & Sharon C. Dutton. 2010. Leibel and Phillips Textbook of Radiation Oncology. Leibel and Phillips Textbook of Radiation Oncology
1473
1489
.
Richard J. Santen. 2010. Endocrinology. Endocrinology
2544
2555
.
Richard J. Wassersug & John L. Oliffe. (2009) The Social Context for Psychological Distress from Iatrogenic Gynecomastia with Suggestions for Its Management. The Journal of Sexual Medicine 6:4, pages 989-1000.
Crossref
Crossref